Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients

Archives of Internal Medicine

Volumn 160, Issue 8, 2000, Pages 1085-1089

  Blacher, Jacques ^a   Staessen, Jan A ^b   Girerd, Xavier ^a   Gasowski, Jerzy ^b   Thijs, Lutgarde ^b   Liu, Lisheng ^c   Wang, Ji G ^c   Fagard, Robert H ^b   Safar, Michel E ^a  

^a HÔPITAL BROUSSAIS   (France)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GERIATRIC PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

EID: 0034709051     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.8.1085     Document Type: Article

References (25)

1. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med. 1997;157:2413-2446.
2. Guidelines Subcommittee. World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 1999; 17:151-183.
3. Nichols WW, O'Rourke MF. Properties of the arterial wall. In: McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 4th ed. London, England: Edward Arnold; 1998.
4. Darné B, Girerd X, Safar M, Cambien F, Guize L. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension. 1989;13:392-400.
5. Rutan GH, Kuller LH. Neaton JD, Wentworth DN, McDonald RH, McFate Smith W. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial, Circulation. 1988;77:504-514.
6. Wilking SVB, Belanger AI, Kannel WB, D'Agostino RB, Steel K. Determinants of isolated systolic hypertension. JAMA. 1988;260:3451-3455.
7. Millar JA, Lever AF, Pulse pressure predicts coronary but not cerebrovascular events in placebo-treated male subjects of the MRC trial [abstract]. J Hypertens. 1996;14(suppl 1):S194.
8. Benetos A, Safar M, Rudnichi A, et al. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension. 1997;30: 1410-1415.
9. Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension. 1994;23:395-401.
10. Fang J, Madhavan S, Cohen H, Alderman MH. Measures of blood pressure and myocardial infarction in treated hypertensive patients. J Hypertens. 1995;13: 413-419.
11. Mitchel GF, Moyé LA, Braunwald E, et al. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. Circulation. 1997;96:4254-4260.
12. Franklin SS, Gustin WIV, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation. 1997;96: 308-315.
13. Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316 099 white men. Arch Intern Med. 1992;152:56-64.
14. Staessen J, Amery A, Fagard R. Isolated systolic hypertension in the elderly. J Hypertens. 1990;8:393-405.
15. Amery A, Birkenhäger W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1985;1:1349-1354.
16. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension [published erratum appears in Lancet. 1997;350:1636]. Lancet. 1997;350: 757-764.
17. Liu L, Wang JG, Gong L, Liu G, Staessen JA, for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo for older patients with isolated systolic hypertension. J Hypertens. 1998; 16:1823-1829.
18. O'Malley K, McCormack P, O'Brien ET. Isolated systolic hypertension: data from the European Working Party on High Blood Pressure in the Elderly. J Hypertens. 1988;6(suppl 1):S105-S108.
19. Abernethy J, Borhani NO, Hawkins CM, et al. Systolic blood pressure as an independent predictor of mortality in the hypertension detection and follow-up program. Am J Prev Med. 1986;2:123-132.
20. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease: the Framingham Study. Am J Cardiol. 1971; 27:335-346.
21. Safar M. Roles of systolic and pulse pressure. Hypertension. 1997;30(pt 1):146-147.
22. Cruickshank JM. Thorp JM. Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet. 1987;1:581-583.
23. Rousso P, Buclin T, Nussberger J, et al. Effects of a dual peptidase inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100240, on endocrine and renal functions in healthy volunteers. J Hypertens. 1999;17: 427-437.
24. Burnett JC Jr. Vasopeptidase inhibition: a new concept in blood pressure management. J Hypertens. 1999;17(suppl 1):S37-S43.
25. Van Bortel LM, Spek JJ, Balkestein EJ, Sardina M, Struijker Boudier HA. Is it possible to develop drugs that act more selectively on large arteries? J Hypertens. 1999:17:701-705.